Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis

Adam Zayac, MD, Andrew Matthew Evens, DO,MMSc, Andrzej Stadnik, MPH, BS, Stephen D. Smith, MD, Deepa Jagadeesh, MDMPH, Lori A. Leslie, MD, Catherine Wei, MD MA, Seo-Hyun Kim, MD, Seema Naik, MD, Suchitra Sundaram, MD, Nishitha Reddy, MD, Umar Farooq, MD, Vaishalee P. Kenkre, MD, Narendranath Epperla, MDMS, Kristie A. Blum, MD, Nadia Khan, MD, Daulath Singh, MD, Juan Pablo Alderuccio, MD, Amandeep Godara, MD, Maryam Yazdy, MD, Catherine Diefenbach, MD, Emma Rabinovich, MD, Gaurav Varma, MDMPH, Reem Karmali, MD, Yusra Shao, MD, Asaad Trabolsi, MD, Madelyn Burkart, MD, Peter Martin, FRCPC, MD MS, Sarah Stettner, Ayushi Chauhan, MBBS, Yun Kyong Choi, MD, Allandria Straker-Edwards, MS, Andreas Klein, MD, Michael C. Churnetski, Kirsten M Boughan, DO, Stephanie Berg, DO, Brad M. Haverkos, MDMPH,MS, Victor M. Orellana-Noia, MD, Christopher D'Angelo, MD, David A. Bond, MD, Seth M Maliske, MD, Ryan Vaca, MD, Gabriela Magarelli, APN, Amy Sperling, BS, Max J. Gordon, MD, Kevin A. David, MD, Paolo Caimi, MD, Manali Kamdar, MD, Craig A. Portell, MD, Parameswaran Venugopal, MD, Izidore S. Lossos, MD, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 402.

https://doi.org/10.1182/blood-2019-122990

Published: 2019

Journal Articles

Potently Cytotoxic Natural Killer Cell Potential Initially Emerges from Erythro-Myeloid Progenitors during Mammalian Development

Carissa Dege, PhD, Katherine H Fegan, MS, J Philip Creamer, IV, BA,BS, Melissa M Berrien-Elliott, PhD, Stephanie A. Luff, PhD, Julia A Wagner, PhD, Paul D. Kingsley, PhD, Kathleen E. McGrath, PhD, Todd A Fehniger, MD PhD, James Palis, MD, Christopher M. Sturgeon, PhD

Blood (2019) 134 (Supplement_1): 2464.

https://doi.org/10.1182/blood-2019-130347

Published: 2019

Journal Articles

Protein Phase Separation in Hematopoietic Stem Cell Aging

Laure Maneix, PhD, Polina Iakova, M.S., Shannon Moree, B.A., Melanie Sweeney, B.A., Nagaishwarya Moka, MD, Sarvari Venkata Yellapragada, MD, Andre Catic, MD PhD

Blood (2019) 134 (Supplement_1): 5003.

https://doi.org/10.1182/blood-2019-124092

Published: 2019

Journal Articles

Assessing Needs for Support in MDS Patients

Esther Natalie Oliva, MD, Raqeebah Agberemi, Sophie Wintrich

Blood (2018) 132 (Supplement 1): 2313.

https://doi.org/10.1182/blood-2018-99-112967

Published: 2018

Journal Articles

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

Jennifer Puck, MD

Blood (2017) 130 (Supplement 1): SCI-30.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-30.SCI-30

Published: 2017

Journal Articles

Biology of PD-1 Checkpoint Blockade

Arlene H. Sharpe, MD PhD

Blood (2017) 130 (Supplement 1): SCI-35.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-35.SCI-35

Published: 2017

Journal Articles

Allogeneic Stem Cell Transplantation in Patients ≥70 Years Old

Christopher C Walling, BS, Pamela A Shaw, PhD, Noelle V Frey, MD, Saar I Gill, MBBS, PhD, Elizabeth O. Hexner, MD, Alison W Loren, MD MS, Selina Luger, MD, James K Mangan, MD PhD, Mary Ellen Martin, MD, Jacqueline Smith, CRNP, Edward A. Stadtmauer, MD, David L. Porter, MD

Blood (2016) 128 (22): 2309.

https://doi.org/10.1182/blood.V128.22.2309.2309

Published: 2016

Journal Articles

Measurement of Quality of Life and Depression of Spouse Caregivers for Survivors after Hematopoietic Stem Cell Transplantation

Silvia Park, Juhee Cho, Jun Ho Jang, Chul Won Jung, Mi Hwa Heo

Blood (2016) 128 (22): 4775.

https://doi.org/10.1182/blood.V128.22.4775.4775

Published: 2016

Journal Articles

Quality of Life Survey in Nonmyeloablative Bone Marrow Transplant Patients at a Large Academic Center

Harsh Shah, DO, Robert Nelson, MD, Jose Azar, MD

Blood (2015) 126 (23): 5612.

https://doi.org/10.1182/blood.V126.23.5612.5612

Published: 2015

Journal Articles

Changes in Expert Recommendations and Global Practice Patterns from 2012-2015: Results from an Annually Updated Online Decision Aid for Multiple Myeloma (MM)

Timothy A Quill, PhD, Shaji K Kumar, MD, Suzanne Lentzsch, Sagar Lonial, MD, G. David Roodman, MD PhD, Erik D. Brady, PhD CHCP, Jim Mortimer, Kevin L Obholz, PhD, Kenneth C Anderson, MD

Blood (2015) 126 (23): 2105.

https://doi.org/10.1182/blood.V126.23.2105.2105

Published: 2015

Journal Articles

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Kristen M Rosenthal, PhD, Christopher R. Flowers, MD, Andre Goy, MD, John P. Leonard, MD, Julie M. Vose, MD, Erik D. Brady, PhD CHCP, Jim Mortimer, Kevin L Obholz, PhD, James O. Armitage, MD

Blood (2015) 126 (23): 4527.

https://doi.org/10.1182/blood.V126.23.4527.4527

Published: 2015

Journal Articles

Impact of Glanzmann’s Thrombasthenia (GT): Perceptions from US Patients and Parents

Michael Recht, MD PhD, Madhvi Rajpurkar, MD, Meera B. Chitlur, MD, Mark Reding, Mary Jane Frey, RN, BSN, CPN, Skye Peltier, MPH, PA-C, Christine Guelcher, MS, PNP-BC, Dana Stephens, RN, MS, CPNP, David L. Cooper, MD MBA

Blood (2014) 124 (21): 4853.

https://doi.org/10.1182/blood.V124.21.4853.4853

Published: 2014

Journal Articles

Patient-Reported Experiences with Treatment of Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Results of a Quantitative Survey

Brad Schenkel, MSc, Ahmad B. Naim, MD, Barbara Roland, MBA, Susan Wyant, PharmD

Blood (2014) 124 (21): 5442.

https://doi.org/10.1182/blood.V124.21.5442.5442

Published: 2014

Journal Articles

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

Chengcheng Liu, Deqing Pei, MS, Cheng Cheng, PhD, Jun J. Yang, PhD, Kristine Crews, PharmD, Wenjian Yang, PhD, Seth E. Karol, MD, Sima Jeha, MD, John T. Sandlund, MD, Raul C Ribeiro, MD, Jeffrey E Rubnitz, MD PhD, Monika L. Metzger, MD MS, Ching-Hon Pui, MD, William E. Evans, PharmD, Mary V. Relling, PharmD

Blood (2014) 124 (21): 3722.

https://doi.org/10.1182/blood.V124.21.3722.3722

Published: 2014

Journal Articles

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

Lindsey Hageman, Wendy Landier, PhD, R.N., Yanjun Chen, MS, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, MD, M.S.H.S., David Dickens, MD, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Arthur K. Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, Mary V. Relling, PharmD, F. Lennie Wong, Smita Bhatia, PhD

Blood (2014) 124 (21): 369.

https://doi.org/10.1182/blood.V124.21.369.369

Published: 2014

Journal Articles

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Smita Bhatia, Ph.D., Wendy Landier, Ph.D., R.N., Lindsey Hageman, Can-Lan Sun, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, M.D., M.S.H.S, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Jane Meza, Ph.D., A. Kim Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, F. Lennie Wong, PhD, Mary V. Relling, PharmD

Blood (2013) 122 (21): 59.

https://doi.org/10.1182/blood.V122.21.59.59

Published: 2013

Journal Articles

CD34+ Circulating Progenitor Cell Frequency Is Highly Heritable

Kenneth S. Cohen, MD, Susan Cheng, MD, Martin G. Larson, ScD, L. Adrienne Cupples, PhD, Elizabeth L. McCabe, MS, Ying A. Wang, PhD, Roderick P. Martin, ALB, Rachael J. Klein, MS, Basma Hashmi, BS, Christopher J. O'Donnell, MD, Vasan S. Ramachandran, MD, Stanley Y. Shaw, MD, PhD, Thomas J. Wang, MD

Blood (2010) 116 (21): 4309.

https://doi.org/10.1182/blood.V116.21.4309.4309

Published: 2010

Journal Articles

Quality of Life in Myelodysplastic Syndromes (MDS): Results from U.S. & European Patient Forums.

Kathy Heptinstall, RN, BSN, the MDS Foundation’s Board of Directors

Blood (2006) 108 (11): 2623.

https://doi.org/10.1182/blood.V108.11.2623.2623

Published: 2006

Journal Articles

Celebrate hematology

Kenneth Kaushansky, MD

Blood (2002) 100 (13): 4257–4258.

https://doi.org/10.1182/blood-2002-09-2984

Published: 2002

NARROW

Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis

Potently Cytotoxic Natural Killer Cell Potential Initially Emerges from Erythro-Myeloid Progenitors during Mammalian Development

Protein Phase Separation in Hematopoietic Stem Cell Aging

Assessing Needs for Support in MDS Patients

Diagnostic Challenges in the Era of Genomic Sequencing and Newborn Screening

Biology of PD-1 Checkpoint Blockade

Allogeneic Stem Cell Transplantation in Patients ≥70 Years Old

Measurement of Quality of Life and Depression of Spouse Caregivers for Survivors after Hematopoietic Stem Cell Transplantation

Quality of Life Survey in Nonmyeloablative Bone Marrow Transplant Patients at a Large Academic Center

Changes in Expert Recommendations and Global Practice Patterns from 2012-2015: Results from an Annually Updated Online Decision Aid for Multiple Myeloma (MM)

Clinical Impact of Internet-Based Tools to Help Guide Therapeutic Decisions for Mantle Cell Lymphoma (MCL)

Impact of Glanzmann’s Thrombasthenia (GT): Perceptions from US Patients and Parents

Patient-Reported Experiences with Treatment of Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL): Results of a Quantitative Survey

Tolerability of 6-Mercaptopurine (6MP) in Patients with Thiopurine Methyltransferase ( TPMT ) Heterozygosity in the Context of Multi-Agent Therapy for Acute Lymphoblastic Leukemia (ALL)

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

CD34+ Circulating Progenitor Cell Frequency Is Highly Heritable

Quality of Life in Myelodysplastic Syndromes (MDS): Results from U.S. & European Patient Forums.

Celebrate hematology

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only